- Home
- TNYA vs YI Comparison
TNYA vs YI Comparison
Compare TNYA & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNYA
- YI
- Stock Information
- Founded
- TNYA 2016
- YI 2010
- Country
- TNYA United States
- YI China
- Employees
- TNYA N/A
- YI N/A
- Industry
- TNYA Medicinal Chemicals and Botanical Products
- YI Retail-Drug Stores and Proprietary Stores
- Sector
- TNYA Health Care
- YI Consumer Staples
- Exchange
- TNYA Nasdaq
- YI Nasdaq
- Market Cap
- TNYA 74.5M
- YI 70.0M
- IPO Year
- TNYA 2021
- YI N/A
- Fundamental
- Price
- TNYA $0.37
- YI $7.89
- Analyst Decision
- TNYA Strong Buy
- YI
- Analyst Count
- TNYA 6
- YI 0
- Target Price
- TNYA $8.60
- YI N/A
- AVG Volume (30 Days)
- TNYA 2.1M
- YI 8.9K
- Earning Date
- TNYA 05-07-2025
- YI 05-22-2025
- Dividend Yield
- TNYA N/A
- YI N/A
- EPS Growth
- TNYA N/A
- YI N/A
- EPS
- TNYA N/A
- YI N/A
- Revenue
- TNYA N/A
- YI $1,973,017,082.00
- Revenue This Year
- TNYA N/A
- YI N/A
- Revenue Next Year
- TNYA N/A
- YI N/A
- P/E Ratio
- TNYA N/A
- YI N/A
- Revenue Growth
- TNYA N/A
- YI N/A
- 52 Week Low
- TNYA $0.39
- YI $0.41
- 52 Week High
- TNYA $4.78
- YI $11.35
- Technical
- Relative Strength Index (RSI)
- TNYA 29.46
- YI 45.70
- Support Level
- TNYA $0.36
- YI $7.61
- Resistance Level
- TNYA $0.53
- YI $7.99
- Average True Range (ATR)
- TNYA 0.04
- YI 0.40
- MACD
- TNYA -0.00
- YI -0.04
- Stochastic Oscillator
- TNYA 3.86
- YI 38.46
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.